Drug Clinical Trials List

Display 161 - 170 from 730

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
The Effect of Rectal Progesterone on the Latency period as well as Maternal and Prenatal Outcome in PPROM Between 24-33+6 Weeks	Umm Al Qura University	Ongoing	Progesterone	3	ISRCTN65694106	UQU
The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial	Dr. Wael Alzhrani (PI-initiated)	Ongoing	Cinnamon	3	100-18	KAUH-J
The effect of (Oligonol) and (Oligonol + metformin) on the components of Metabolic Syndrome in obese individuals- A randomized, double-blind, factorial clinical trial.	Amino Up Chemical Co., Ltd.	Terminated	Oligonol	3	SDRG- Amino Up 1	KFMRC-J
Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled	Sanofi	Completed	Lantus®	3	LANTU_C_02762	KFUH
"Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy"	Inovio Pharmaceuticals, Inc.	Completed	NO-4700 + CELLECTRA™ 2000 (device)	2	MERS-201	KSMC
Study of Aflibercept in Uveitic Macular EDema (SAUD study)	King Khalid Specialist Hospital	Rejected	Aflibercept	3b	18176	KKESH
"Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial with an open-label extension that investigates the effect of the addition of dulaglutide (0.75 and 1.5 mg/week) or placebo weekly to metformin and/or basal insulin on change from baseline in hemoglobin A1c at 26 weeks in children and adolescents with type 2 diabetes mellitus"	Eli Lilly	Ongoing	Dulaglutide 0.75 /1.5 mg	3	H9X-MC-GBGC	KKUH
Standard Induction with Basiliximab versus No-Induction in Low Immunological Risk Kidney Transplant Recipients Prospective Randomized Double Blind Controlled Clinical Trial	King Faisal Specialist Hospital and Research Centre	Ongoing	BASILIXIMAB (SIMULECT)	3	2191177	King Faisal Specialist Hospital and Research Center (Riyadh)
SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety	SPIMACO	Ongoing	Fastulin R / Normulin N	3	N/A (version 1.4) Aug 2011	KFMC
"Somatostatin as inflow modulator in Adult-to-Adult living donor liver transplantation. A randomized, double-blind, placebo-controlled trial"	King Faisal Specialist Hospital and Research Centre	Ongoing	Somatostatin	3	2191109	KFSH & RC-R